Poly(ADP-ribose) polymerase (PARP) inhibitors for the treatment of ovarian cancer.

ABSTRACT:

SUBMITTER: Tattersall A 

PROVIDER: S-EPMC8848772 | biostudies-literature | 2022 Feb

REPOSITORIES: biostudies-literature